Compugen Ltd.
NASDAQ: CGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eran Ophir
- Employees
- 74
- Headquarters
- Holon, Israel
- IPO year
- 2000
- Market cap
- $190.1M
- Website
- https://cgen.com
Loading CGEN…
Loading profile data…Frequently asked questions about CGEN
What does Compugen Ltd. (CGEN) do?
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe. The company’s core activities center around its immuno-oncol...
Where does CGEN trade?
Compugen Ltd. (CGEN) trades on the NASDAQ Global Market.
What sector is CGEN in?
Compugen Ltd. (CGEN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Compugen Ltd.?
Eran Ophir is the chief executive officer of Compugen Ltd. (CGEN).
Where is Compugen Ltd. headquartered?
Compugen Ltd. is headquartered in Israel.
Does CGEN pay a dividend?
Compugen Ltd. (CGEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CGEN go public?
Compugen Ltd. (CGEN) completed its initial public offering in 2000.